D-Index & Metrics Best Publications

John T. Sandlund

National Institutes of Health
United States

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 90 Citations 23,131 238 World Ranking 7789 National Ranking 4192

Overview

What is he best known for?

The fields of study John T. Sandlund is best known for:

Cancer
Chemotherapy
Leukemia

His Internal medicine study frequently draws connections to other fields, such as Confidence interval. His research on Confidence interval often connects related topics like Internal medicine. His work blends Leukemia and Myeloid studies together. His Myeloid study frequently draws connections between related disciplines such as Immunology. As part of his studies on Immunology, John T. Sandlund often connects relevant subjects like Myeloid leukemia. In his research, he undertakes multidisciplinary study on Myeloid leukemia and Gene. His study deals with a combination of Gene and Phenotype. John T. Sandlund combines Phenotype and Genetics in his studies. While working in this field, John T. Sandlund studies both Genetics and Cancer research.

His most cited work include:

Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital (198 citations)
11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia. (196 citations)
Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia. (186 citations)

What are the main themes of his work throughout his whole career to date

His Internal medicine study frequently links to other fields, such as Disease. In his works, John T. Sandlund performs multidisciplinary study on Leukemia and Bone marrow. In his research, John T. Sandlund undertakes multidisciplinary study on Bone marrow and Leukemia. In his study, John T. Sandlund carries out multidisciplinary Chemotherapy and Acute lymphocytic leukemia research. John T. Sandlund conducted interdisciplinary study in his works that combined Acute lymphocytic leukemia and Chemotherapy. In his research, he undertakes multidisciplinary study on Oncology and Gastroenterology. John T. Sandlund connects Gastroenterology with Oncology in his research. John T. Sandlund merges Immunology with Biochemistry in his research. John T. Sandlund integrates Biochemistry with Immunology in his study.

John T. Sandlund most often published in these fields:

Internal medicine (85.42%)
Leukemia (64.58%)
Chemotherapy (52.08%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Treating childhood acute lymphoblastic leukemia without cranial irradiation.

Ching Hon Pui;Dario Campana;Deqing Pei;W. Paul Bowman.
The New England Journal of Medicine (2009)

1262 Citations

Mercaptopurine Therapy Intolerance and Heterozygosity at the Thiopurine S-Methyltransferase Gene Locus

Mary V. Relling;Michael L. Hancock;Gaston K. Rivera;John T. Sandlund.
Journal of the National Cancer Institute (1999)

827 Citations

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.

C H Pui;R C Ribeiro;M L Hancock;G K Rivera.
The New England Journal of Medicine (1991)

819 Citations

Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia.

Elaine Coustan-Smith;Jose Sancho;Michael L. Hancock;James M. Boyett.
Blood (2000)

663 Citations

Improved outcome for children with acute lymphoblastic leukemia: Results of Total Therapy Study XIIIB at St Jude Children's Research Hospital

Ching Hon Pui;John T. Sandlund;Deqing Pei;Dario Campana.
Blood (2004)

579 Citations

Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia.

Ching Hon Pui;Cheng Cheng;Wing Leung;Shesh N. Rai.
The New England Journal of Medicine (2003)

524 Citations

Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia

C H Pui;M V Relling;J T Sandlund;J R Downing.
Annals of Hematology (2004)

519 Citations

Non-Hodgkin's Lymphoma in Childhood

John T. Sandlund;James R. Downing;William M. Crist.
The New England Journal of Medicine (1996)

511 Citations

Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia.

Elaine Coustan-Smith;Jose Sancho;Frederick G. Behm;Michael L. Hancock.
Blood (2002)

386 Citations

Cumulative Incidence of Secondary Neoplasms as a First Event After Childhood Acute Lymphoblastic Leukemia

Nobuko Hijiya;Melissa M. Hudson;Shelly Lensing;Margie Zacher.
JAMA (2007)

357 Citations

If you think any of the details on this page are incorrect, let us know.

Frequent Co-Authors

External Links

Personal Website for John T. Sandlund